Molecular Markers and Potential Therapeutic Targets in Non-WNT/Non-SHH (Group 3 and Group 4) Medulloblastomas
Journal of Hematology and Oncology - United Kingdom
doi 10.1186/s13045-019-0712-y
Full Text
Open PDFAbstract
Available in full text
Date
March 15, 2019
Authors
Publisher
Springer Science and Business Media LLC